Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis
Authors:
- Keiichi TakiueKTKeiichi Takiue
- Hitoshi SugiyamaHSHitoshi Sugiyama
- Tatsuyuki InoueTITatsuyuki Inoue
- Hiroshi MorinagaHMHiroshi Morinaga
- Yoko KikumotoYKYoko Kikumoto
- Masashi KitagawaMKMasashi Kitagawa
- Shinji KitamuraSKShinji Kitamura
- Yohei MaeshimaYMYohei Maeshima
- Da-Hong WangDWDa-Hong Wang
- Noriyoshi MasuokaNMNoriyoshi Masuoka
- Keiki OginoKOKeiki Ogino
- Hirofumi MakinoHMHirofumi Makino
Open Access
- 25 March 2012
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 13 (1) , 14
Abstract
Background: Catalase is an important antioxidant enzyme that regulates the level of intracellular hydrogen peroxide and hydroxyl radicals. The effects of catalase deficiency on albuminuria and progressive glomerulosclerosis have not yet been fully elucidated. The adriamycin (ADR) nephropathy model is considered to be an experimental model of focal segmental glomerulosclerosis. A functional catalase deficiency was hypothesized to exacerbate albuminuria and the progression of glomerulosclerosis in this model. Methods: ADR was intravenously administered to both homozygous acatalasemic mutant mice (C3H/AnLCsbCsb) and control wild-type mice (C3H/AnLCsaCsa). The functional and morphological alterations of the kidneys, including albuminuria, renal function, podocytic, glomerular and tubulointerstitial injuries, and the activities of catalase were then compared between the two groups up to 8 weeks after disease induction. Moreover, the presence of a mutation of the toll-like receptor 4 (tlr4) gene, which was previously reported in the C3H/HeJ strain, was investigated in both groups. Results: The ADR-treated mice developed significant albuminuria and glomerulosclerosis, and the degree of these conditions in the ADR-treated acatalasemic mice was higher than that in the wild-type mice. ADR induced progressive renal fibrosis, renal atrophy and lipid peroxide accumulation only in the acatalasemic mice. In addition, the level of catalase activity was significantly lower in the kidneys of the acatalasemic mice than in the wild-type mice during the experimental period. The catalase activity increased after ADR injection in wild-type mice, but the acatalasemic mice did not have the ability to increase their catalase activity under oxidative stress. The C3H/AnL strain was found to be negative for the tlr4 gene mutation. Conclusions: These data indicate that catalase deficiency plays an important role in the progression of renal injury in the ADR nephropathy model.Keywords
This publication has 43 references indexed in Scilit:
- Development of Angiotensin II-induced Abdominal Aortic Aneurysms Is Independent of Catalase in MiceJournal of Cardiovascular Pharmacology, 2011
- The Role of Catalase in Pulmonary FibrosisRespiratory Research, 2010
- Over-expression of adenosine deaminase in mouse podocytes does not reverse puromycin aminonucleoside resistanceBMC Nephrology, 2010
- Evolution of Catalases from Bacteria to HumansAntioxidants & Redox Signaling, 2008
- Therapeutic targets in focal and segmental glomerulosclerosisCurrent Opinion in Nephrology and Hypertension, 2008
- RAGE Mediates Podocyte Injury in Adriamycin-induced GlomerulosclerosisJournal of the American Society of Nephrology, 2008
- Effects of Gestational Diethylstilbestrol Treatment on Male and Female Gonads during Early Embryonic DevelopmentEndocrinology, 2008
- Depletion of γδ T Cells Exacerbates Murine Adriamycin NephropathyJournal of the American Society of Nephrology, 2007
- Regulation of survival and death of mesangial cells by extracellular matrixKidney International, 1998
- Blood Catalase Polymorphism: Some Immunological AspectsScience, 1968